On Oct. 18, 2021, Gilead Sciences announced that the Food and Drug Administration had approved a new low-dose…
On Oct. 15, 2021, Merck announced that the European Medicines Agencyﾒs Committee for Medicinal Products for Human Use…
On Oct. 15, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals,…
On Oct. 15, 2021, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Tecentriq (atezolizumab)…
On Oct. 15, 2021, Pfizer and BioNTech announced they had submitted data supporting the vaccination of children 5…
On Oct. 14, 2021, the U.S. Department of Agriculture’s Agriculture Research Service (ARS) announced confirmation of SARS-CoV-2 (the…
On Oct. 14, 2021, The NIH Rapid Acceleration of Diagnostics (RADx) initiative announced that it has issued contract…
On Oct. 14, 2021, Moderna confirmed that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological…
On Oct. 14, 2021, the World Health Organization announced that the COVID-19 pandemic had reversed years of global…
On Oct. 14, 2021, Regeneron announced that the U.S. Food and Drug Administration (FDA) had accepted for priority…
On Oct. 14, 2021, Cepheid announced it had received the CE mark for Xpert Xpress CoV-2/Flu/RSV plus, a…
On Oct. 13, 2021, the World Health Organization (WHO) honoured the late Henrietta Lacks with a WHO Director-General’s…
On Oct. 13, 2021, the Ministry of Health of the Democratic Republic of the Congo announced that vaccination…
On Oct. 12, 2021, Lucira Health announced that it had received PSAR approval for its Lucra CHECK IT…
On Oct. 12, 2021, National Resilience announced a strategic collaboration with Children’s Hospital of Philadelphia (CHOP) to implement…
On Oct. 12, 2021, Inovio Pharmaceuticals announced online preprint publication in MedRxiv of Phase 1 clinical data on…
On Oct. 12, 2021, Moderna announced that Gavi, the Vaccine Alliance had exercised its option to purchase an…
On Oct. 11, 2021, Merck and Ridgeback Biotherapeutics announced that Merck had submitted an Emergency Use Authorization (EUA)…
On Oct. 11, 2021, scientists at Washington University School of Medicine in St. Louis announced they had developed…
On Oct. 11, 2021, Inovio Pharmaceuticals announced that it had received authorization from Colombia’s INVIMA, to conduct the…
On Oct. 8, 2021, the Ministry of Health of the Democratic Republic of the Congo announced that a…
On Oct. 7, 2021, Moderna announced it was building a state-of-the-art mRNA facility in Africa with the goal…
On Oct. 7, 2021, Vaxart announced that a Duke University-led study published in bioRxiv showed that Vaxart’s (investigational…
On Oct. 7, 2021, BD (Becton, Dickinson) announced it had strengthened the U.S. government’s access to safety injection…
On Oct. 7, 2021, the Centers for Disease Control and Prevention (CDC) reported One U.S. child loses a…
On Oct. 7, 2021, the World Health Organization launched the Strategy to Achieve Global Covid-19 Vaccination by mid-2022…
On Oct. 7, 2021, PerkinElmer announced that the U.S. Food and Drug Administration (FDA) had issued Emergency Use…
On Oct. 6, 2021, Washington University School of Medicine announced the start of a pediatric COVID-19 vaccine clinical…
On Oct. 6, 2021, AIM ImmunoTech released detailed safety data from a Phase 1 clinical study which supported…
On Oct. 6, 2021, the The NIH Brain Research through Advancing Innovative Neurotechnologiesﾮ (BRAIN?) Initiative Cell Census Network…